| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | -0.07 | 0.02 |
| mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | -0.076 | 0.02 |
| mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | -0.067 | 0.03 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.067 | 0.03 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.03 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.03 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.078 | 0.03 |
| mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | 0.072 | 0.03 |